May 2, 2016, Workshop on LC/MS-Based Devices
The Food and Drug Administration (FDA) is holding a public workshop on May 2, 2016, entitled "Mass Spectrometry in the Clinic: Regulatory Consideration Surrounding Validation of Liquid Chromatography - Mass Spectrometry Based Devices."
The purpose of the workshop is to obtain information on current and anticipated uses for LC/MS as well as different validation approaches. The FDA says is wishes to enhance engagement with the clinical LC/MS community concerning the development and validation of LC/MS- based devices and to work with the community toward developing guidelines for review that will be useful and relevant to both FDA and manufacturers.
For information about the workshop, and instructions for registering, click here.